Business Description
Inventionmed SA
ISIN : PLCDE0000010
Description
Inventionmed SA focuses on the development of medical simulators based on VR technology for use in education in esthetic and clinical dermatology. The firm's flagship project consists of TutorDerm, a simulator and an application that allow performing the activities necessary to treat specific dermatological conditions.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | 0.1 | |||||
| Debt-to-Equity | 0.83 | |||||
| Debt-to-EBITDA | -2.63 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -1.09 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | -26 | |||||
| 3-Year FCF Growth Rate | -51.5 | |||||
| 3-Year Book Growth Rate | -39.7 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.93 | |||||
| 9-Day RSI | 36.09 | |||||
| 14-Day RSI | 39.88 | |||||
| 6-1 Month Momentum % | -9.44 | |||||
| 12-1 Month Momentum % | 15.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.03 | |||||
| Quick Ratio | 0.03 | |||||
| Days Sales Outstanding | 3294.32 | |||||
| Days Payable | 3810.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 4.5 | |||||
| Shareholder Yield % | -2.29 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -131.92 | |||||
| Operating Margin % | -5848.94 | |||||
| Net Margin % | -8965.96 | |||||
| FCF Margin % | -15082.98 | |||||
| ROE % | -68.62 | |||||
| ROA % | -11 | |||||
| ROIC % | -5.59 | |||||
| ROC (Joel Greenblatt) % | -10.39 | |||||
| ROCE % | -10.63 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 10.63 | |||||
| Price-to-Tangible-Book | 10.1 | |||||
| Price-to-Operating-Cash-Flow | 101 | |||||
| EV-to-EBIT | -16.08 | |||||
| EV-to-EBITDA | -35.71 | |||||
| EV-to-Revenue | 940.62 | |||||
| EV-to-FCF | -6.24 | |||||
| Earnings Yield (Greenblatt) % | -6.22 | |||||
| FCF Yield % | -17.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Inventionmed SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil zł) | 0.047 | ||
| EPS (TTM) (zł) | -0.021 | ||
| Beta | 0.95 | ||
| Volatility % | 56.14 | ||
| 14-Day RSI | 39.88 | ||
| 14-Day ATR (zł) | 0.009467 | ||
| 20-Day SMA (zł) | 0.21185 | ||
| 12-1 Month Momentum % | 15.62 | ||
| 52-Week Range (zł) | 0.17 - 0.318 | ||
| Shares Outstanding (Mil) | 202.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Inventionmed SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Inventionmed SA Stock Events
| Event | Date | Price(zł) | ||
|---|---|---|---|---|
| No Event Data | ||||
Inventionmed SA Frequently Asked Questions
What is Inventionmed SA(WAR:INM)'s stock price today?
The current price of WAR:INM is zł0.20. The 52 week high of WAR:INM is zł0.32 and 52 week low is zł0.17.
When is next earnings date of Inventionmed SA(WAR:INM)?
The next earnings date of Inventionmed SA(WAR:INM) is .
Does Inventionmed SA(WAR:INM) pay dividends? If so, how much?
Inventionmed SA(WAR:INM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers